263 related articles for article (PubMed ID: 22998687)
1. Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.
Fiocca R; Mastracci L; Attwood SE; Ell C; Galmiche JP; Hatlebakk J; Bärthel A; Långström G; Lind T; Lundell L;
Aliment Pharmacol Ther; 2012 Nov; 36(10):959-71. PubMed ID: 22998687
[TBL] [Abstract][Full Text] [Related]
2. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.
Sanduleanu S; De Bruïne A; Stridsberg M; Jonkers D; Biemond I; Hameeteman W; Lundqvist G; Stockbrügger RW
Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723
[TBL] [Abstract][Full Text] [Related]
3. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial.
Lundell L; Havu N; Miettinen P; Myrvold HE; Wallin L; Julkunen R; Levander K; Hatlebakk JG; Liedman B; Lamm M; Malm A; Walan A;
Aliment Pharmacol Ther; 2006 Mar; 23(5):639-47. PubMed ID: 16480403
[TBL] [Abstract][Full Text] [Related]
4. The gastric mucosa 25 years after proximal gastric vagotomy.
Sagatun L; Jianu CS; Fossmark R; Mårvik R; Nordrum IS; Waldum HL
Scand J Gastroenterol; 2014 Oct; 49(10):1173-80. PubMed ID: 25157752
[TBL] [Abstract][Full Text] [Related]
5. Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.
Hatlebakk JG; Zerbib F; Bruley des Varannes S; Attwood SE; Ell C; Fiocca R; Galmiche JP; Eklund S; Långström G; Lind T; Lundell LR;
Clin Gastroenterol Hepatol; 2016 May; 14(5):678-85.e3. PubMed ID: 26226096
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Hirschowitz BI; Haber MM
Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
[TBL] [Abstract][Full Text] [Related]
7. Effects of 6-12 months of esomeprazole treatment on the gastric mucosa.
Genta RM; Rindi G; Fiocca R; Magner DJ; D'Amico D; Levine DS
Am J Gastroenterol; 2003 Jun; 98(6):1257-65. PubMed ID: 12818266
[TBL] [Abstract][Full Text] [Related]
8. Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa.
Rindi G; Fiocca R; Morocutti A; Jacobs A; Miller N; Thjodleifsson B;
Eur J Gastroenterol Hepatol; 2005 May; 17(5):559-66. PubMed ID: 15827447
[TBL] [Abstract][Full Text] [Related]
9. Changes in gene expression of gastric mucosa during therapeutic acid inhibition.
Nørsett KG; Laegreid A; Kusnierczyk W; Langaas M; Ylving S; Fossmark R; Myhre S; Falkmer S; Waldum HL; Sandvik AK
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):613-23. PubMed ID: 18679062
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
11. Effect of proton-pump inhibitor therapy on serum chromogranin a level.
Pregun I; Herszényi L; Juhász M; Miheller P; Hritz I; Patócs A; Rácz K; Tulassay Z
Digestion; 2011; 84(1):22-8. PubMed ID: 21304238
[TBL] [Abstract][Full Text] [Related]
12. Effects of very long (up to 10 years) proton pump blockade on human gastric mucosa.
Lamberts R; Brunner G; Solcia E
Digestion; 2001; 64(4):205-13. PubMed ID: 11842276
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia.
Waldum HL; Rehfeld JF
Scand J Gastroenterol; 2019 Sep; 54(9):1118-1123. PubMed ID: 31524029
[TBL] [Abstract][Full Text] [Related]
14. Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease.
Vakil N
Gastroenterol Clin North Am; 2015 Sep; 44(3):661-6. PubMed ID: 26314675
[TBL] [Abstract][Full Text] [Related]
15. Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance.
Lamberts R
Microsc Res Tech; 2000 Mar; 48(6):357-66. PubMed ID: 10738317
[TBL] [Abstract][Full Text] [Related]
16. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.
Lundell L; Vieth M; Gibson F; Nagy P; Kahrilas PJ
Aliment Pharmacol Ther; 2015 Sep; 42(6):649-63. PubMed ID: 26177572
[TBL] [Abstract][Full Text] [Related]
17. Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease.
Brunner G; Athmann C; Schneider A
Aliment Pharmacol Ther; 2012 Jul; 36(1):37-47. PubMed ID: 22531114
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group.
Lundell L; Miettinen P; Myrvold HE; Pedersen SA; Thor K; Andersson A; Hattlebakk J; Havu N; Janatuinen E; Levander K; Liedman B; Nyström P
Gastroenterology; 1999 Aug; 117(2):319-26. PubMed ID: 10419912
[TBL] [Abstract][Full Text] [Related]
19. Hypergastrinemia after Helicobacter pylori infection is associated with bacterial load and related inflammation of the oxyntic corpus mucosa.
Chuang CH; Sheu BS; Yang HB; Kao AW; Cheng HC; Yao WJ
J Gastroenterol Hepatol; 2004 Sep; 19(9):988-93. PubMed ID: 15304114
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
